Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in RVMD — Revolution Medicines, Inc.

CIK 861177 NEW YORK, NY

Position in RVMD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$170,862,094
+$122,179,234 QoQ
Shares Held
912,335
+82.3% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#43
of 687 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 58% Shared 0% None 42%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. RVMD ranks #5 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 RVMD
Revolution Medicines, Inc.
This page
912,335 $170,862,094

All Filings in RVMD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $170,862,094 912,335
2026-03-31 $48,682,860 500,595
2025-12-31 $27,830,662 349,412
2025-09-30 $15,941,835 341,367
2025-06-30 $18,420,638 500,697
2025-03-31 $10,614,928 300,196
2024-12-31 $11,497,099 262,851
2024-09-30 $9,796,776 216,026
2024-06-30 $9,370,555 241,447
2024-03-31 $4,292,196 133,174
2023-12-31 $3,819,429 133,174
2023-09-30 $2,885,306 104,238
2023-06-30 $2,416,192 90,325
2023-03-31 $1,956,437 90,325
2022-12-31 $1,498,300 62,901
2022-09-30 $867,501 43,991
2022-06-30 $848,397 43,530
2022-03-31 $1,467,794 57,538
2021-12-31 $1,027,287 40,814
2021-09-30 $1,068,266 38,832
2021-06-30 $1,220,719 38,460
2021-03-31 $1,023,124 22,300
2020-12-31 $982,980 24,829
2020-09-30 $247,080 7,100